Kristine Paridaens

10PUBLICATIONS
43CO-AUTHORS
Rheumatology and arthritisMedical biochemistry - proteins and peptides (incl. medical proteomics)Food properties (incl. characteristics and health benefits)Pharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 14, 2024
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis-The OPTIMISE Study.

Silvio Danese, Gionata Fiorino, Eric Vicaut

|May 11, 2024
Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey.

Ferdinando D'Amico, Vipul Jairath, Kristine Paridaens

|Nov 25, 2023
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.

Tommaso Lorenzo Parigi, Sophie Vieujean, Kristine Paridaens

|Jul 27, 2023
Efficacy of oral prolonged-release mesalazine in moderately active ulcerative colitis.

Kristine Paridaens, John R Fullarton, Simon P L Travis

|Feb 11, 2023
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis.

Ferdinando D'Amico, Fernando Magro, Benedicte Caron

|Nov 15, 2022
Non-invasive monitoring and treat-to-target approach are cost-effective in patients with mild-moderate ulcerative colitis.

Paolo Angelo Cortesi, Gionata Fiorino, Laurent Peyrin-Biroulet

Pageof 2

Frequent Collaborators

3 joint publications

Silvio Danese

3 joint publications

Simon P L Travis

3 joint publications

John R Fullarton

2 joint publications

Petra Weimers